 JUPITER, Fla., Nov. 16, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Marizyme Inc. Marizyme or the Company OTCQB:MRZM, is pleased to announce the hiring of Mr. David Barthel as the Chief Executive Officer for Marizyme. In his role Mr. Barthel will look to advance the Companys technology pipeline and stay committed to the commercialization efforts of DuraGraft in Europe and Asia while focusing on the FDA submissions for DuraGraft and MATLOC 1 in the US. In addition, Mr. Barthel will lead the Company through its financing initiatives, strengthening the financial position of the Company in preparation for an anticipated Nasdaq listing in 2022. 